Publication | Open Access
Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy
18
Citations
27
References
2018
Year
Hematological MalignancyMedicineMalignant Blood DisorderBiological CharacteristicsHematologyImmunologyCombination TherapyPharmacotherapyImmunotherapyOncologyTumor MicroenvironmentCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1